A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigrostriatal dopaminergic pathway

The pattern of enkephalin immunoreactivity was examined in the adult rat neostriatum, at various times after unilateral removal of the nigrostriatal dopamine input by 6-hydroxydopamine injection into the medial forebrain bundle. Animals were examined 12 days, 26 days or 13 months after the lesion. Enkephalin-immunoreactive synaptic boutons (n = 1018) in the control and the dopamine-depleted neostriatum were analysed in the electron microscope. The area of enkephalin-immunoreactive synaptic bouton profiles was significantly larger in the dopamine-depleted neostriatum and this increase was maximal in rats in which the lesion had been made 26 days or 13 months previously (50% increase). The synaptic specializations of these enkephalin-immunoreactive boutons were significantly longer in the neostriatum from the injected side. Dendritic shafts were the principal postsynaptic target of these boutons (67%) but dendritic spines (18%), perikarya (6.5%) and unidentifiable small dendrites or spines (8.5%) were also contacted. The proportions of enkephalin-immunoreactive boutons on the different postsynaptic targets were not altered by the 6-hydroxydopamine lesion. The increase in enkephalin immunoreactivity observed in the dopamine-depleted neostriatum in previous studies may be explained by the increase in the size of enkephalin-immunoreactive synaptic boutons found in the present ultrastructural investigation. The observations do not rule out the possibility that there is also an increase in the number of immunoreactive synaptic boutons, due to, for example, sprouting of the existing enkephalin-containing fibres.

[1]  R. North.  Minireview opiates, opioid peptides and single neurones , 1979 .

[2]  C. Finch,et al.  Senescent change in tissue weight and immunoreactive β-endorphin, enkephalin, and vasopressin in eight regions of C57BL/6J mouse brain and pituitary , 1985, Neurobiology of Aging.

[3]  B. Bloch,et al.  Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment , 1987, Neuroscience Letters.

[4]  A. D. Smith,et al.  Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium‐size spiny neurons in the rat neostriatum , 1988, The Journal of comparative neurology.

[5]  T. F. Freund,et al.  Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines , 1984, Neuroscience.

[6]  P. Somogyi,et al.  Synaptic connections of enkephalin-immunoreactive nerve terminals in the neostriatum: a correlated light and electron microscopic study , 1982, Journal of neurocytology.

[7]  Y. Kubota,et al.  Ultrastructural evidence of dopaminergic input to enkephalinergic neurons in rat neostriatum , 1986, Brain Research.

[8]  J. McGinty,et al.  Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes , 1990, Brain Research.

[9]  M. Garcia-Munoz,et al.  Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation , 1987, Neuropharmacology.

[10]  O. Bosler,et al.  Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: Immunohistochemical evidence , 1986, Neuroscience Letters.

[11]  M. Olianas,et al.  Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice , 1987, Neuroscience Letters.

[12]  C. Feuerstein,et al.  Similar Time Course Changes in Striatal Levels of Glutamic Acid Decarboxylase and Proenkephalin mRNA Following Dopaminergic Deafferentation in the Rat , 1988, Journal of neurochemistry.

[13]  E. Reynolds.  THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY , 1963, The Journal of cell biology.

[14]  S. Johnson,et al.  Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6-hydroxydopamine in rat ventral tegmental area (VTA) , 1989, Brain Research.

[15]  T. Hökfelt,et al.  Immunohistochemical studies using antibodies to leucine-enkephalin: Initial observations on the nervous system of the rat , 1976, Neuroscience.

[16]  J. Fallon,et al.  The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a Striatopallidal system , 1983, The Journal of comparative neurology.

[17]  H. Groenewegen,et al.  Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions , 1987, Brain Research.

[18]  R. Wurtman,et al.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization , 1980, Brain Research.

[19]  G. Breese,et al.  Neonatal and Adult 6‐Hydroxydopamine‐Induced Lesions Differentially Alter Tachykinin and Enkephalin Gene Expression , 1987, Journal of neurochemistry.

[20]  T. Hökfelt,et al.  Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. , 1982, European journal of pharmacology.

[21]  G. Paxinos,et al.  Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus , 1982, Brain Research.

[22]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[23]  P. Sarkar,et al.  Regulation of α- and β-tubulin mRNAs in rat brain during synaptogenesis , 1987 .

[24]  T. Powell,et al.  The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. , 1971, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[25]  H. Kita,et al.  Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations , 1988, Brain Research.

[26]  V. Petkov,et al.  Age-related changes in brain neurotransmission. , 1988, Gerontology.

[27]  T. Bonner,et al.  Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. , 1986, The Journal of biological chemistry.

[28]  M. Ariano.  Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway , 1988, Brain Research.

[29]  C. Marsden,et al.  Age-related decreases in the concentration of Met-and Leu-enkephalin and neurotensin in the basal ganglia of rats , 1987, Neuroscience Letters.

[30]  C. Meshul,et al.  Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment , 1989, Brain Research.

[31]  D. Reis,et al.  Immunocytochemical localization of enkephalin in the neostriatum of rat brain: A light and electron microscopic study , 1980, The Journal of comparative neurology.

[32]  J. Joyce,et al.  Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis , 1989, Brain Research.

[33]  W. Fratta,et al.  Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum , 1979, Brain Research.

[34]  L. Thal,et al.  Striatal met-enkephalin concentration increases following nigrostriatal denervation. , 1983, Biochemical pharmacology.

[35]  G. Lahoste,et al.  Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action , 1989, Brain Research.

[36]  M. Martone,et al.  Three-dimensional pattern of enkephalin-like immunoreactivity in the caudate nucleus of the cat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  G. Paxinos,et al.  Evidence for a long Leu-enkephalin striopallidal pathway in rat brain , 1978, Nature.

[38]  B. Bloch,et al.  Dopamine receptor gene expression by enkephalin neurons in rat forebrain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Costa,et al.  Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes. , 1987, The Journal of pharmacology and experimental therapeutics.

[40]  M. Ariano.  Long-term changes in striatal D1 dopamine receptor distribution after dopaminergic deafferentation , 1989, Neuroscience.

[41]  C. Gerfen,et al.  Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study , 1988, Brain Research.

[42]  D. Pfaff,et al.  Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization. , 1987, Brain research.

[43]  H. Fibiger,et al.  Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway , 1978, Brain Research.

[44]  S. Boyce,et al.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis) , 1990, Brain Research.

[45]  G. Di Chiara,et al.  D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions. , 1986, European journal of pharmacology.

[46]  A. Graybiel,et al.  Characterization of substance P- and [MET]enkephalin-immunoreactive neurons in the caudate nucleus of cat and ferret by a single section golgi procedure , 1987, Neuroscience.

[47]  B. Morris,et al.  Dopaminergic regulation of striatal proenkephalin mrna and prodynorphin mrna: Contrasting effects of d1 and d2 antagonists , 1988, Neuroscience.

[48]  G. Uhl,et al.  Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Somogyi,et al.  Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the golgi‐peroxidase transport‐degeneration procedure , 1981, The Journal of comparative neurology.

[50]  R. North,et al.  Drug receptors and the inhibition of nerve cells , 1989, British journal of pharmacology.

[51]  S. Afsharpour,et al.  The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin-and substance P-immunoreactive neurons in the neostriatum of the rat and cat: Evidence for partial population overlap , 1986, Neuroscience.

[52]  I. Kanazawa,et al.  Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain , 1977, Brain Research.

[53]  A. Crossman,et al.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat , 1990, Brain Research.

[54]  J. Marshall,et al.  Neural plasticity and recovery of function after brain injury. , 1985, International review of neurobiology.

[55]  U. Ungerstedt,et al.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. , 1970, Brain research.

[56]  N. A. Buchwald,et al.  Ultrastructural alterations in caudate nucleus in aged cats , 1988, Brain Research.

[57]  J. Powell,et al.  Tyrosine hydroxylase-immunoreactive neurons of the hypothalamus: A light and electron microscopic study , 1984, Neuroscience.

[58]  Y. Mizuno,et al.  Changes in γ-aminobutyrate, glutamate, aspartate, glycine, and taurine contents in the striatum after unilateral nigrostriatal lesions in rats , 1986, Experimental Neurology.

[59]  G. Arbuthnott,et al.  Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age , 1989, Brain Research.

[60]  N. Aronin,et al.  Light and electron microscopic localization of immunoreactive Leu- enkephalin in the monkey basal ganglia , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  P M Field,et al.  A quantitative investigation of the development of collateral reinnervation after partial deafferentation of the septal nuclei. , 1973, Brain research.

[62]  M. Memo,et al.  Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol , 1987, Neuropharmacology.

[63]  J. P. Schwartz,et al.  Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Bonner,et al.  Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[65]  H. Y. Yang,et al.  Increase of striatal Met5-enkephalin-Arg6-Phe7 (YGGFMRF) content elicited by long-term treatment with haloperidol. , 1984, The Journal of pharmacology and experimental therapeutics.

[66]  P. Savard,et al.  Age-related changes in central nervous system enkephalins and substance P. , 1981, Life sciences.

[67]  J. Burgunder,et al.  Distribution, projection and dopaminergic regulation of the neurokinin B mRNA-containing neurons of the rat caudate-putamen , 1989, Neuroscience.

[68]  M. Zigmond,et al.  Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum. , 1985, European journal of pharmacology.